Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta

Daisuke Kobayashi, Ichiro Ieiri, Takeshi Hirota, Hiroshi Takane, Shinji Maegawa, Junzo Kigawa, Hiroshi Suzuki, Eiji Nanba, Mitsuo Oshimura, Naoki Terakawa, Kenji Otsubo, Kazunori Mine, Yuichi Sugiyama

Research output: Contribution to journalArticle

224 Citations (Scopus)

Abstract

The aim of the present study was to assess the contribution of polymorphisms in the breast cancer resistance protein/ATP-binding cassette transporter G2 (BCRP/ABCG2) gene to the placental expression from a new perspective, allelic imbalance. Polymorphisms were screened by polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis followed by sequencing with DNA extracted from 100 placentas. To examine whether polymorphisms of the BCRP gene correlate with the placental BCRP expression, we determined mRNA and protein levels by quantitative real-time PCR and Western blotting, respectively. In placentas, G34A (Val12Met) and C421A (Gln141Lys) were frequently observed (18-36%), but C376T, which creates a stop codon (Gln126 stop codon), was found with an allelic frequency of 1%. The mean of the BCRP protein level was significantly lower (p < 0.05) in homozygotes for the A421 allele than in those for the C421 allele, and heterozygotes had an intermediate value. To evaluate whether the C421A polymorphism acts as a cis-element in BCRP transcription, allelic imbalance was determined using informative lymphoblasts and 56 samples of placental cDNA. In most of the placental samples we tested, the difference in expression levels between the two alleles was small, and only two samples indicated a monoallellic expression (i.e., preferential expression of one allele). These results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.

Original languageEnglish
Pages (from-to)94-101
Number of pages8
JournalDrug Metabolism and Disposition
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Placenta
Alleles
Allelic Imbalance
Terminator Codon
Genes
Proteins
ATP-Binding Cassette Transporters
Homozygote
Heterozygote
DNA Sequence Analysis
Protein Binding
Real-Time Polymerase Chain Reaction
Complementary DNA
Western Blotting
Breast Neoplasms
Polymerase Chain Reaction
Messenger RNA
Mutation

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta. / Kobayashi, Daisuke; Ieiri, Ichiro; Hirota, Takeshi; Takane, Hiroshi; Maegawa, Shinji; Kigawa, Junzo; Suzuki, Hiroshi; Nanba, Eiji; Oshimura, Mitsuo; Terakawa, Naoki; Otsubo, Kenji; Mine, Kazunori; Sugiyama, Yuichi.

In: Drug Metabolism and Disposition, Vol. 33, No. 1, 01.01.2005, p. 94-101.

Research output: Contribution to journalArticle

Kobayashi, D, Ieiri, I, Hirota, T, Takane, H, Maegawa, S, Kigawa, J, Suzuki, H, Nanba, E, Oshimura, M, Terakawa, N, Otsubo, K, Mine, K & Sugiyama, Y 2005, 'Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta', Drug Metabolism and Disposition, vol. 33, no. 1, pp. 94-101. https://doi.org/10.1124/dmd.104.001628
Kobayashi, Daisuke ; Ieiri, Ichiro ; Hirota, Takeshi ; Takane, Hiroshi ; Maegawa, Shinji ; Kigawa, Junzo ; Suzuki, Hiroshi ; Nanba, Eiji ; Oshimura, Mitsuo ; Terakawa, Naoki ; Otsubo, Kenji ; Mine, Kazunori ; Sugiyama, Yuichi. / Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta. In: Drug Metabolism and Disposition. 2005 ; Vol. 33, No. 1. pp. 94-101.
@article{48d1bb9cee9341829b5956c13d98bc96,
title = "Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta",
abstract = "The aim of the present study was to assess the contribution of polymorphisms in the breast cancer resistance protein/ATP-binding cassette transporter G2 (BCRP/ABCG2) gene to the placental expression from a new perspective, allelic imbalance. Polymorphisms were screened by polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis followed by sequencing with DNA extracted from 100 placentas. To examine whether polymorphisms of the BCRP gene correlate with the placental BCRP expression, we determined mRNA and protein levels by quantitative real-time PCR and Western blotting, respectively. In placentas, G34A (Val12Met) and C421A (Gln141Lys) were frequently observed (18-36{\%}), but C376T, which creates a stop codon (Gln126 stop codon), was found with an allelic frequency of 1{\%}. The mean of the BCRP protein level was significantly lower (p < 0.05) in homozygotes for the A421 allele than in those for the C421 allele, and heterozygotes had an intermediate value. To evaluate whether the C421A polymorphism acts as a cis-element in BCRP transcription, allelic imbalance was determined using informative lymphoblasts and 56 samples of placental cDNA. In most of the placental samples we tested, the difference in expression levels between the two alleles was small, and only two samples indicated a monoallellic expression (i.e., preferential expression of one allele). These results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.",
author = "Daisuke Kobayashi and Ichiro Ieiri and Takeshi Hirota and Hiroshi Takane and Shinji Maegawa and Junzo Kigawa and Hiroshi Suzuki and Eiji Nanba and Mitsuo Oshimura and Naoki Terakawa and Kenji Otsubo and Kazunori Mine and Yuichi Sugiyama",
year = "2005",
month = "1",
day = "1",
doi = "10.1124/dmd.104.001628",
language = "English",
volume = "33",
pages = "94--101",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Functional assessment of ABCG2 (BRCP) gene polymorphisms to protein expression in human placenta

AU - Kobayashi, Daisuke

AU - Ieiri, Ichiro

AU - Hirota, Takeshi

AU - Takane, Hiroshi

AU - Maegawa, Shinji

AU - Kigawa, Junzo

AU - Suzuki, Hiroshi

AU - Nanba, Eiji

AU - Oshimura, Mitsuo

AU - Terakawa, Naoki

AU - Otsubo, Kenji

AU - Mine, Kazunori

AU - Sugiyama, Yuichi

PY - 2005/1/1

Y1 - 2005/1/1

N2 - The aim of the present study was to assess the contribution of polymorphisms in the breast cancer resistance protein/ATP-binding cassette transporter G2 (BCRP/ABCG2) gene to the placental expression from a new perspective, allelic imbalance. Polymorphisms were screened by polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis followed by sequencing with DNA extracted from 100 placentas. To examine whether polymorphisms of the BCRP gene correlate with the placental BCRP expression, we determined mRNA and protein levels by quantitative real-time PCR and Western blotting, respectively. In placentas, G34A (Val12Met) and C421A (Gln141Lys) were frequently observed (18-36%), but C376T, which creates a stop codon (Gln126 stop codon), was found with an allelic frequency of 1%. The mean of the BCRP protein level was significantly lower (p < 0.05) in homozygotes for the A421 allele than in those for the C421 allele, and heterozygotes had an intermediate value. To evaluate whether the C421A polymorphism acts as a cis-element in BCRP transcription, allelic imbalance was determined using informative lymphoblasts and 56 samples of placental cDNA. In most of the placental samples we tested, the difference in expression levels between the two alleles was small, and only two samples indicated a monoallellic expression (i.e., preferential expression of one allele). These results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.

AB - The aim of the present study was to assess the contribution of polymorphisms in the breast cancer resistance protein/ATP-binding cassette transporter G2 (BCRP/ABCG2) gene to the placental expression from a new perspective, allelic imbalance. Polymorphisms were screened by polymerase chain reaction (PCR)-single-strand conformation polymorphism analysis followed by sequencing with DNA extracted from 100 placentas. To examine whether polymorphisms of the BCRP gene correlate with the placental BCRP expression, we determined mRNA and protein levels by quantitative real-time PCR and Western blotting, respectively. In placentas, G34A (Val12Met) and C421A (Gln141Lys) were frequently observed (18-36%), but C376T, which creates a stop codon (Gln126 stop codon), was found with an allelic frequency of 1%. The mean of the BCRP protein level was significantly lower (p < 0.05) in homozygotes for the A421 allele than in those for the C421 allele, and heterozygotes had an intermediate value. To evaluate whether the C421A polymorphism acts as a cis-element in BCRP transcription, allelic imbalance was determined using informative lymphoblasts and 56 samples of placental cDNA. In most of the placental samples we tested, the difference in expression levels between the two alleles was small, and only two samples indicated a monoallellic expression (i.e., preferential expression of one allele). These results suggest that 1) the predominant allelic expression pattern of BCRP in placental samples is biallelic, and 2) the mutation C421A is not a genetic variant acting in cis, but is considered to influence the translation efficiency.

UR - http://www.scopus.com/inward/record.url?scp=19944399722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944399722&partnerID=8YFLogxK

U2 - 10.1124/dmd.104.001628

DO - 10.1124/dmd.104.001628

M3 - Article

VL - 33

SP - 94

EP - 101

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 1

ER -